These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 27287696)

  • 21. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
    Bao M; Li H; Li J
    BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
    Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
    N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.
    Haissman JM; Knudsen A; Hoel H; Kjær A; Kristoffersen US; Berge RK; Katzenstein TL; Svardal A; Ueland T; Aukrust P; Lebech AM; Nielsen SD; Trøseid M
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):130-6. PubMed ID: 26413854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
    Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
    J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.
    Li XS; Obeid S; Wang Z; Hazen BJ; Li L; Wu Y; Hurd AG; Gu X; Pratt A; Levison BS; Chung YM; Nissen SE; Tang WHW; Mach F; Räber L; Nanchen D; Matter CM; Lüscher TF; Hazen SL
    Eur Heart J; 2019 Aug; 40(32):2700-2709. PubMed ID: 31049589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
    Ivashkin VT; Kashukh YA
    Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
    [No Abstract]   [Full Text] [Related]  

  • 28. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease.
    Bjørnestad EØ; Dhar I; Svingen GFT; Pedersen ER; Ørn S; Svenningsson MM; Tell GS; Ueland PM; Sulo G; Laaksonen R; Nygård O
    J Intern Med; 2022 Dec; 292(6):915-924. PubMed ID: 35916742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
    Koay YC; Chen YC; Wali JA; Luk AWS; Li M; Doma H; Reimark R; Zaldivia MTK; Habtom HT; Franks AE; Fusco-Allison G; Yang J; Holmes A; Simpson SJ; Peter K; O'Sullivan JF
    Cardiovasc Res; 2021 Jan; 117(2):435-449. PubMed ID: 32267921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.
    Miller PE; Haberlen SA; Brown TT; Margolick JB; DiDonato JA; Hazen SL; Witt MD; Kingsley LA; Palella FJ; Budoff M; Jacobson LP; Post WS; Sears CL
    J Acquir Immune Defic Syndr; 2016 May; 72(1):114-8. PubMed ID: 26825179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
    Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
    Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
    Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
    Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trimethylamine N-oxide in cardiovascular disease.
    Konieczny RA; Kuliczkowski W
    Adv Clin Exp Med; 2022 Aug; 31(8):913-925. PubMed ID: 35438848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
    Liu G; Li J; Li Y; Hu Y; Franke AA; Liang L; Hu FB; Chan AT; Mukamal KJ; Rimm EB; Sun Q
    Am J Clin Nutr; 2021 Jul; 114(1):238-247. PubMed ID: 33829245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.